top of page

Nasal Peptide Research: Interpreting Permeability and Absorption

Writer: Colt Clemons
Colt Clemons
May 17
2 min read

Updated: Oct 10

Intranasal delivery studies ask whether a specific preparation can reach a measured target under defined conditions. The words “nasal spray” do not establish blood-brain barrier bypass, precise output or clinical effectiveness. This guide explains how to read permeability and absorption claims without extending them beyond the evidence.


Separate delivery route from measured outcome


A route describes how a preparation was studied. An outcome describes what investigators actually measured. These may include concentrations in a sampled compartment, molecular markers or behavior. A change in one measure does not establish all of the others.


Born and colleagues’ 2002 human study investigated a transnasal approach using selected neuropeptides. It is a primary research paper about particular experimental preparations, not a validation of every nasal compound or commercial spray.



Read the study model before the headline


Find out whether the work used cells, animals or human participants. Note the compound, formulation and endpoint. A rat study on a molecular marker is not a human trial of symptom improvement. For example, the Semax paper below examined rat hippocampal BDNF and trkB expression; its results should be described within that scope.



Check five details before comparing preparations


Identity: record the exact compound or blend. Similar names do not establish equivalence.


Formulation: distinguish total container content, stated concentration and the formulation tested in the paper. Do not calculate concentration from an empty container’s capacity.


Delivery device: a pump or spray format does not by itself establish the amount delivered with each actuation. That requires information for the specific device and preparation.


Endpoint: record what was measured, the comparison group and the uncertainty. Detection in a sample is different from proof of a meaningful clinical effect.


Limitations: check whether stability, tolerability or other performance claims were actually assessed. Avoid universal statements such as “stress-free,” “exact delivery” or “no tissue damage” when the cited evidence does not establish them.


What a product page can tell you


A listing can identify the supplied material, format and stated contents. It cannot make a published experiment transferable to a different preparation. Check the current listing and contact Premier Aminos when a specification needed for your work is not stated.




Related research and scope


For compound-specific examples and the distinction between NAD+ and peptides, read the companion evidence overview.



This is research-literature guidance, not a protocol or a recommendation for human or animal use. Premier Aminos research compounds are for laboratory research only.


 
 
 

Comments


bottom of page